Humatrope Kit
Product Images NDC 0002-8149

Product Visual Gallery

This gallery contains 108 technical images submitted to the FDA as part of the official labeling for Humatrope (NDC 0002-8149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Htr Cart 1 V1)

An instructional diagram of the HUMATROPE kit components by Eli Lilly and Company. It shows a diluent syringe labeled with a plunger, diluent, and needle cover. Next to it is the Humatrope cartridge with black triangles, expiration date, and white tip. The diagram also includes an end cap illustration.*

FDA Label Image

Figure (Htr Cart 2 V1)

Instructional illustration showing a HUMATROPE kit by Eli Lilly and Company, featuring a syringe with a Lilly label and vial for intramuscular or subcutaneous injection. A hand is depicted placing or removing the vial, with an inset showing hand washing, indicating preparation steps prior to use.*

FDA Label Image

Figure (Htr Cart 3 V1)

An instructional diagram showing a hand holding a syringe labeled 'Lilly,' with annotations pointing to the plunger at the top and the needle cover at the bottom. The illustration demonstrates how to hold the syringe, likely related to administering HUMATROPE (somatropin) injection.*

FDA Label Image

Figure (Htr Cart 4 V1)

An instructional illustration showing hands holding a HUMATROPE injection pen. The top panel highlights the plunger labeled with Eli Lilly, while the bottom panel shows the needle cover being removed with a downward arrow indicating the action.*

FDA Label Image

Figure (Htr Cart 5 V1)

An instructional illustration showing proper handling of a HUMATROPE injection device, highlighting the correct positioning of the device with visible black triangles and cautioning against an incorrect grip indicated by a red prohibition symbol.*

FDA Label Image

Figure (Htr Cart 6 V1)

An instructional illustration showing a person holding a syringe-like device labeled with 'Lilly'. The illustration depicts the action of removing a needle cap using both hands, indicated by a black upward arrow.*

FDA Label Image

Figure (Htr Cart 7 V1)

Illustration showing a hand holding a syringe labeled with 'Lilly.' The diagram highlights the plunger of the syringe, depicting downward arrows indicating the plunger being pressed. This instructional image appears to demonstrate the action of pushing the syringe plunger, likely related to the HUMATROPE injection kit use.*

FDA Label Image

Figure (Htr Cart 8 V1)

An instructional illustration showing a hand holding a syringe with the label 'Lilly' on it, demonstrating the action of rotating or twisting a part of the syringe with the thumb. This likely depicts a step in preparing or using the injection device for HUMATROPE, a somatropin kit by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Cart 9 V1)

An instructional illustration showing two hands preparing a HUMATROPE injection device by Eli Lilly and Company, demonstrating how to connect or align the syringe and pen components for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Cart 10 V1)

An instructional illustration showing a hand holding a Lilly-branded pen injector device vertically above a circular button or base, with a downward-pointing arrow indicating the device should be pressed or positioned down onto the surface.*

FDA Label Image

Figure (Htr Cart 11 V1)

A black and white instructional diagram showing a hand holding a HUMATROPE injection device. The illustration demonstrates rotating the device 10 times as indicated by a curved arrow and the number 'x 10.' This likely represents a step in preparing the device for use.*

FDA Label Image

Figure (Htr Cart 12 V1)

The image shows a clear single-use syringe containing a liquid medication, part of the HUMATROPE (Somatropin) kit for intramuscular or subcutaneous injection, labeled by Eli Lilly and Company. The syringe has a transparent barrel and a plunger with visible markings.*

FDA Label Image

Figure (Htr Ifu 6mg 1 V2)

Humatrope 6 mg cartridge in a dosing pen device, labeled with the brand name and active ingredient somatropin (rDNA origin). The pen is white with green accents and has a dosage window showing measurement markings. The product is a kit for intramuscular or subcutaneous administration by Eli Lilly and Company.*

FDA Label Image

Figure (Logo)

FDA Label Image

Figure (Htr Ifu 6mg 2 V2)

An exploded view illustration of the HUMATROPE 6 mg kit components for intramuscular or subcutaneous use, labeled with each part. Components include the pen cap, 6 mg cartridge with rubber seal and white tip, screw, front housing, pen body with dose window and dose knob, and the injection button. The cartridge is noted as sold separately. The diagram visually explains the pen assembly parts for HUMATROPE by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu Needle Parts V2)

An illustration showing the parts of a pen needle for use with HUMATROPE (Somatropin) kit. The labeled components include the outer cap, inner cap, needle, and paper tab. The image notes that pen needles are not included.*

FDA Label Image

Figure (Htr Ifu Hnc Optional V1)

Packaging label for HUMATROPE kit by Eli Lilly and Company showing a hidden needle cover. The cover is cylindrical, white with green and yellow accents, and features the Lilly logo in gray. This component is optional and included with the medication for intramuscular or subcutaneous use.*

FDA Label Image

Figure (Htr Ifu Case V2)

HUMATROPE storage case in green for the Somatropin kit by Eli Lilly and Company. The rectangular case has a simple design with the Lilly logo embossed subtly on the front. It is intended for storing the HUMATROPE injection kit for intramuscular or subcutaneous use.*

FDA Label Image

Figure (Htr Ifu 6mg 3 V2)

An illustration showing a hand holding a Humatrope Somatropin injectable pen. The label on the pen displays the brand name Humatrope, with a 6 mg dosage indicated. The pen is designed for intramuscular or subcutaneous administration as part of a kit by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 6mg 4 V2)

An illustration showing a hand holding a small vial labeled with an "Expiration Date" arrow pointing to the vial. The image is instructional, indicating where to locate the expiration date on the vial, related to the HUMATROPE Somatropin kit.*

FDA Label Image

Figure (Htr Ifu 6mg 5 V2)

An instructional illustration showing hands preparing a HUMATROPE kit for injection. One hand holds an injection pen device, while the other hand is pulling the protective cap off the pen, indicated by a red arrow pointing away from the device. The illustration demonstrates part of the setup process for administering HUMATROPE intramuscularly or subcutaneously.*

FDA Label Image

Figure (Htr Ifu 6mg 6 V2)

Humatrope 6 mg vial label showing the product name, dosage strength (6 mg), and labeler Eli Lilly and Company. The vial is designed for intramuscular or subcutaneous injection. The image includes close-up views of the vial cap indicating the 6 mg dosage and a partially removed outer seal revealing the vial contents.*

FDA Label Image

Figure (Htr Ifu 6mg 7 V2)

An instructional illustration showing the connection of a HUMATROPE somatropin cartridge with a medication delivery device. The white tip of the cartridge aligns with a screw mechanism on the device. This diagram highlights the assembly step for preparing HUMATROPE for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Ifu 6mg 8 V2)

An instructional illustration demonstrating how to handle and unwrap a HUMATROPE kit for injection. The image shows two hands holding a product component with a red arrow indicating the direction to peel off a red protective seal or cap from the kit. The kit is labeled with the proprietary name HUMATROPE and dosage information.*

FDA Label Image

Figure (Htr Ifu Pull Tab V2)

An instructional illustration showing hands removing a protective cap from a vial or syringe by pulling the cap upwards. This is likely part of the preparation steps for using HUMATROPE (Somatropin) kit, a prescription drug for intramuscular or subcutaneous injection by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 6mg 9 V1)

The image shows a hand removing or attaching a protective cap from the tip of a cartridge or injector pen labeled HUMATROPE, a Somatropin kit for intramuscular or subcutaneous use. The label on the cartridge indicates a strength of 6 mg and the manufacturer Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 6mg 10 V2)

An instructional illustration showing how to remove the cap from a Humatrop pen before use. It depicts a hand holding the pen and another hand pulling off the transparent cap, indicated by a red arrow pointing left. The pen label shows Humatrop with 6 mg strength.*

FDA Label Image

Figure (Htr Ifu 6mg 11 V2)

An instructional illustration depicting the setting of a dosing device for HUMATROPE (Somatropin) kit. The image shows a hand adjusting the dial on a syringe-like device to set a specific dose before injection via intramuscular or subcutaneous route.*

FDA Label Image

Figure (Htr Ifu 6mg 12 V2)

An instructional illustration showing hands holding and preparing a HUMATROPE (Somatropin) injection kit. The image focuses on attaching or removing a needle from the syringe, with a magnified close-up of the needle tip and syringe connection. The syringe contains an orange liquid, suggesting drug preparation for intramuscular or subcutaneous injection.*

FDA Label Image

Figure (Htr Ifu 6mg 13 V2)

An instructional illustration showing a person removing the protective cap from a HUMATROPE injection pen. The hands hold the pen and the cap is being pulled off, indicated by a red arrow. The image highlights preparation for subcutaneous or intramuscular administration of the drug.*

FDA Label Image

Figure (Htr Ifu 6mg 14 V2)

An illustration showing a hand holding a labeled syringe pen with a visible dosage window marked at 6 mg, designed for subcutaneous or intramuscular injection, corresponding to the HUMATROPE Somatropin kit by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 6mg 15 V1)

An instructional illustration showing a hand removing the cap from a Humatrope cartridge, labeled 6 mg. The image demonstrates preparation for intramuscular or subcutaneous injection of Humatrope (Somatropin), a human prescription drug kit by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 6mg 16 V2)

Instructional illustration depicting a person adjusting the dose on a HUMATROPE (Somatropin) injection pen by turning a dose selector knob, highlighting the dosage scale visible on the device. The pen is labeled with the Lilly brand name.*

FDA Label Image

Figure (Htr Ifu Inj Sites V2)

Illustration showing the recommended intramuscular and subcutaneous injection sites for HUMATROPE (Somatropin). Highlighted areas include the abdomen, front thighs, outer upper arms, and upper buttocks on a human figure viewed from front and back.*

FDA Label Image

Figure (Htr Ifu 6mg 17 V2)

An instructional illustration showing a hand holding a syringe injecting medication into the side of a person's finger. An arrow indicates the direction of injection, and a clock symbol with '5 seconds' text suggests holding the injection for five seconds. This diagram is related to administering HUMATROPE (Somatropin) by intramuscular or subcutaneous injection.*

FDA Label Image

Figure (Htr Ifu 6mg 18 V2)

Close-up image of a dosage measurement label on a HUMATROPE Somatropin kit syringe. The visible part of the label shows a graduated scale for precise dosing, indicating measurements between 0.00 and 0.25 units. The syringe includes a white plunger and a yellow-green section, consistent with the HUMATROPE product design by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 6mg 19 V2)

Instructional illustration showing a person removing the protective cap from a HUMATROPE (Somatropin) injectable kit vial. The image demonstrates preparation steps for intramuscular or subcutaneous injection using the Eli Lilly and Company HUMATROPE kit.*

FDA Label Image

Figure (Htr Ifu 6mg 20 V2)

An illustration showing the preparation of a HUMATROPE kit by Eli Lilly and Company, featuring a dosing syringe with a visible 6 mg label and an arrow indicating the removal of a red protective cap. The diagram demonstrates handling for intramuscular or subcutaneous injection of somatropin.*

FDA Label Image

Figure (Htr Ifu 6mg 21 V2)

An instructional illustration showing how to prepare a dose using a HUMATROPE Somatropin injection pen. The image depicts hands removing the protective cap from the pen before use, indicated by a red arrow pointing away from the pen.*

FDA Label Image

Figure (Htr Ifu Info Comp)

FDA Label Image

Figure (Htr Ifu Exclamation)

FDA Label Image

Figure (Htr Ifu Info Book)

An instructional diagram showing the use of a pen device for drug administration. The image includes three steps: 1) Remove the injection needle cover, 2) Push the injection button to deliver the medication, and 3) Remove and dispose of the needle. The illustration highlights the device and the injection method visually.*

FDA Label Image

Figure (Htr Ifu Umbrella)

FDA Label Image

Figure (Htr Ifu Temp)

An illustration of a thermometer indicating a temperature range from -40°F to 156°F.*

FDA Label Image

Figure (Htr Ifu Ce)

FDA Label Image

Figure (Htr Ifu Mfg)

FDA Label Image

Figure (Htr Ifu Ec Rep)

FDA Label Image

Figure (Htr Ifu Symbol Table)

An instructional diagram that explains icons related to medical device information: patient information website, designation as a medical device, single patient multiple use, and unique device identifier (UDI). Each icon is paired with corresponding text clarifying its meaning.*

FDA Label Image

Figure (Htr Ifu 12mg 1 V2)

HUMATROPE 12 mg kit containing Somatropin (rDNA origin) in an injection pen device. The pen features a label with dosage information and the Lilly logo on the dosing dial, indicating Eli Lilly and Company as the labeler. The pen is designed for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Ifu 12mg 2 V2)

An exploded view illustration of the HUMATROPE 12 mg cartridge pen injector kit showing its components: pen cap, 12 mg cartridge with rubber seal and white tip, front housing with screw, 12 mg pen body, dose window, dose knob, and injection button. The cartridge is sold separately, and the device is designed for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Ifu 12mg 3 V2)

Illustration showing a hand holding a Humatrope kit syringe labeled for somatropin injection, 12 mg. The syringe is designed for intramuscular or subcutaneous use and is produced by Eli Lilly and Company. The image presents a front view of the product in use.*

FDA Label Image

Figure (Htr Ifu 12mg 4 V2)

An instructional illustration showing a hand holding a HUMATROPE kit component, indicating where to find the expiration date on the back view of the product. The image highlights locating the expiration date label on the device.*

FDA Label Image

Figure (Htr Ifu 12mg 5 V2)

Instructional illustration showing hands assembling a device kit for HUMATROPE (Somatropin). One hand is pulling a cap off a pen-like injector device, preparing it for use via intramuscular or subcutaneous injection.*

FDA Label Image

Figure (Htr Ifu 12mg 6 V2)

HUMATROPE 12 mg kit for intramuscular and subcutaneous use, labeled with Somatropin as the active ingredient. The image shows the drug cartridge with a green and white color scheme, featuring '12 mg' dosage indicated on the end cap and label. Manufactured by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 12mg 7 V2)

An instructional illustration showing how to connect the white tip of a Humatropes (Somatropin) cartridge to a device by screwing it in. The image highlights the white tip on the cartridge and the screw mechanism on the device, indicating assembly steps for use.*

FDA Label Image

Figure (Htr Ifu 12mg 8 V2)

An instructional illustration showing the use of a HUMATROPE somatropin injection pen. The image depicts hands twisting the pen components, indicated by red arrows, to prepare the device for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Ifu 12mg 9 V1)

An instructional illustration showing the proper connection of a needle to the Humatrope 12 mg kit pen device. The image features a hand attaching the needle to the pen, indicating the preparation step for subcutaneous or intramuscular administration of Humatrope (somatropin).*

FDA Label Image

Figure (Htr Ifu 12mg 10 V2)

An instructional diagram showing how to attach a needle to a HUMATROPE (Somatropin) injection device. The image demonstrates a hand holding the needle cap and another hand holding the HUMATROPE vial, with a red arrow indicating the direction to connect the needle to the vial for intramuscular or subcutaneous injection.*

FDA Label Image

Figure (Htr Ifu 12mg 11 V2)

An instructional illustration showing a close-up of a hand adjusting the dose on a HUMATROPE (Somatropin) dose measurement device, highlighting the dosage scale in milligrams for intramuscular or subcutaneous injection.*

FDA Label Image

Figure (Htr Ifu 12mg 12 V2)

Instructional illustration showing hands preparing a HUMATROPE Somatropin injection kit. The image depicts a close-up of a syringe needle attached to a vial, with an arrow indicating an upward motion on the syringe, demonstrating how to prepare the injection for intramuscular or subcutaneous use.*

FDA Label Image

Figure (Htr Ifu 12mg 13 V2)

An instructional illustration showing hands removing the protective cap from a pen injector device for HUMATROPE (somatropin) kit. The image visually guides users on preparing the pen for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Ifu 12mg 14 V2)

Illustration showing a hand holding a HUMATROPE injection pen, a device used for administering Somatropin. The pen is yellow with a dosage display indicating 12 mg, demonstrating how the user sets or reads the dose on the injection device.*

FDA Label Image

Figure (Htr Ifu 12mg 15 V1)

An instructional illustration depicting a hand removing a red protective cap from a Humatrope 12 mg somatropin injection pen. The image highlights preparation steps for intramuscular or subcutaneous administration of the human prescription drug kit by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 12mg 16 V2)

Illustration showing the use of an injection pen with a dose window displaying dosage amounts. The pen includes a label with "Lilly" and instructions indicated by an upward red arrow on a red tab, suggesting dose adjustment or administration steps.*

FDA Label Image

Figure (Htr Ifu 12mg 17 V2)

An instructional illustration showing how to use a HUMATROPE (somatropin) injection kit. It depicts one hand holding and pressing the injection device against the finger of the opposite hand with a five-second timer indicating the duration to maintain the injection.*

FDA Label Image

Figure (Htr Ifu 12mg 18 V2)

Close-up image of a dosing device component from a HUMATROPE kit, showing a measurement scale with a setting at 0.00. HUMATROPE (Somatropin) KIT is a human prescription drug for intramuscular and subcutaneous use, labeled by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 12mg 19 V2)

An instructional illustration demonstrating how to remove the protective cap from a HUMATROPE kit syringe. The image shows a hand holding the syringe with a label visible, and an arrow indicating the removal of the cap to prepare for intramuscular or subcutaneous injection.*

FDA Label Image

Figure (Htr Ifu 12mg 20 V2)

An instructional illustration showing a person removing the cap from a Humatrope injection pen. The pen is labeled with the product name, somatropin (rDNA origin), and strength of 12 mg. The instructions demonstrate how to prepare the device for intramuscular or subcutaneous injection.*

FDA Label Image

Figure (Htr Ifu 12mg 21 V2)

An instructional illustration showing hands assembling a pen device with a visible HUMATROPE label. The image demonstrates removing a transparent cap from the pen injector, indicated by a red arrow pointing away from the pen's tip.*

FDA Label Image

Figure (Htr Ifu 24mg 1 V2)

The image shows a HUMATROPE 24 mg Somatropin injection pen. The pen is primarily green with a clear chamber displaying the product label, which includes the brand and generic names. It is labeled for human prescription use by Eli Lilly and Company, designed for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Ifu 24mg 2 V2)

Illustrated diagram of the HUMATROPE kit components, including the pen cap, 24 mg cartridge with rubber seal and white tip, screw, front housing, 24 mg pen body with dose window, dose knob, and injection button. The cartridge is sold separately from the pen body components.*

FDA Label Image

Figure (Htr Ifu 24mg 3 V2)

Illustration showing a hand holding a Humatrope kit syringe labeled with Somatropin solution, intended for intramuscular or subcutaneous injection. The label includes the brand name Humatrope and identifies it as somatropin, produced by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 24mg 4 V2)

An instructional illustration showing a hand holding a HUMATROPE injection pen, with a label pointing to the expiration date on the back of the pen. The image is intended to guide users to locate the expiration date on the product.*

FDA Label Image

Figure (Htr Ifu 24mg 5 V2)

An instructional illustration demonstrating the removal of a protective cap from a green injection pen, held in one hand while the other hand pulls the cap away with a red arrow indicating the direction of removal. This relates to the preparation of the HUMATROPE Somatropin injection kit for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Ifu 24mg 6 V2)

HUMATROPE 24 mg injection cartridge kit by Eli Lilly and Company. The images show a green and white cartridge labeled with "24 mg" dosage, designed for intramuscular or subcutaneous administration, as part of a prescription drug kit.*

FDA Label Image

Figure (Htr Ifu 24mg 7 V2)

An instructional diagram illustrating the connection of a Humatrope injection pen kit. It shows the white tip of the Humatrope cartridge aligning with the screw mechanism of the pen device, indicating how to attach the cartridge to the injector for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Ifu 24mg 8 V2)

An instructional illustration showing how to twist and attach the red cap onto a HUMATROPE Somatropin injection pen device. The image depicts two hands holding the pen, guiding the attachment in a clockwise motion, suggesting preparation for subcutaneous or intramuscular administration.*

FDA Label Image

Figure (Htr Ifu 24mg 9 V1)

An instructional illustration showing a hand removing a protective cap from a HUMATROPE 24 mg Somatropin cartridge, part of a kit for intramuscular or subcutaneous administration. The cartridge is labeled with the product name, strength, and is manufactured by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 24mg 10 V2)

Illustration showing a hand holding a HUMATROPE Somatropin syringe kit and another hand removing the protective cap from the needle. The syringe contains a 2.6 mg dosage labeled HUMATROPE. The image demonstrates preparation steps for intramuscular or subcutaneous injection.*

FDA Label Image

Figure (Htr Ifu 24mg 11 V2)

An instructional illustration showing a close-up of a dosing dial on a HUMATROPE Somatropin kit. A hand is adjusting the dose with a red arrow indicating the direction for turning the dial to select a specific dose measurement marked on the dial.*

FDA Label Image

Figure (Htr Ifu 24mg 12 V2)

An instructional illustration showing hands holding a syringe connected to a HUMATROPE kit. The image highlights the needle and the dosage markings, demonstrating the assembly or preparation process for injection with the HUMATROPE somatropin kit by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 24mg 13 V2)

An instructional illustration showing hands removing the protective cap from a green and white HUMATROPE (Somatropin) injection pen, used for intramuscular or subcutaneous administration. The focus is on preparing the injection device for use.*

FDA Label Image

Figure (Htr Ifu 24mg 14 V2)

An illustration showing a hand holding a Humatrop kit pen device, which is used for intramuscular or subcutaneous administration of somatropin. The pen displays a dosage setting of 2.4 mg, with a green body and a purple dosage indicator.*

FDA Label Image

Figure (Htr Ifu 24mg 15 V1)

An instructional illustration showing a hand removing a cap from a Humatrope (Somatropin) injection pen or syringe. The image highlights the preparation step for subcutaneous or intramuscular administration of the drug, labeled with the dosage strength of 24 mg.*

FDA Label Image

Figure (Htr Ifu 24mg 16 V2)

An instructional illustration showing a hand holding a device labeled 'Lilly' with a dosage window displaying '1.00'. A red arrow points upward from a red tab at the device's end, indicating a step to pull or adjust the tab, likely part of preparing the HUMATROPE injection kit by Eli Lilly and Company for use.*

FDA Label Image

Figure (Htr Ifu 24mg 17 V2)

Instructional illustration showing the administration of HUMATROPE (Somatropin) using an injection device. The image depicts a hand pressing the device against the skin of the thigh or arm, with an arrow indicating the injection action and a clock icon recommending holding for 5 seconds.*

FDA Label Image

Figure (Htr Ifu 24mg 18 V2)

Close-up image of a dosing window on the HUMATROPE kit, showing a digital-like display reading "0.00." The kit is green and white, designed for intramuscular or subcutaneous administration, labeler Eli Lilly and Company.*

FDA Label Image

Figure (Htr Ifu 24mg 19 V2)

An instructional illustration showing the removal of a protective cap from a HUMATROPE (Somatropin) injection pen or cartridge. A hand grips the pen, and a red arrow indicates the direction to pull off the cap, demonstrating preparation for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Ifu 24mg 20 V2)

Illustration showing the use of a Humatrope kit featuring somatropin (rDNA origin) for injection. The image depicts hands adjusting the dosage on the dosage dial, identifying 2.4 mg strength, illustrating preparation for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Ifu 24mg 21 V2)

An instructional illustration showing the assembly of a HUMATROPE injection device. The image depicts a hand holding a capped syringe being connected to the injection pen, with a red arrow indicating the direction to attach the syringe to the pen prior to administration.*

FDA Label Image

Figure (Htr Hnc 1 V2)

HUMATROPE kit container with a yellow cap, labeled with Lilly branding. The container is white with a green base and features a stylized yellow graphic on the front. Designed for intramuscular or subcutaneous administration, this product is labeled by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Hnc 2 V2)

An instructional illustration showing components and locking mechanism of a HUMATROPE drug delivery device. The diagram labels the guide channel, guide post, slider, and body of the device on the left. On the right are two close-up views showing the device in locked and unlocked states with the position of the guide post and slider highlighted.*

FDA Label Image

Figure (Htr Hnc Locked V2)

Illustration showing the locked position of a yellow-colored component with directional arrows pointing to the locked state, likely part of an injection device or kit mechanism for the HUMATROPE somatropin kit.*

FDA Label Image

Figure (Htr Hnc 3 V2)

An instructional illustration showing hands assembling a HUMATROPE kit component by inserting or attaching a vial or cartridge part, indicated by a red directional arrow. The image demonstrates proper handling or preparation steps for the Somatropin injection kit by Eli Lilly and Company for intramuscular or subcutaneous administration.*

FDA Label Image

Figure (Htr Hnc Unlocked V2)

An illustration showing the lock mechanism on a device, with a yellow dial positioned pointing to an open padlock icon, labeled 'Unlocked' beneath. This likely indicates the device is in the unlocked state, possibly related to usage or safety settings for the HUMATROPE injection kit by Eli Lilly and Company.*

FDA Label Image

Figure (Htr Hnc 4 V2)

Illustration showing a close-up of a HUMATROPE (Somatropin) drug delivery device, demonstrating the step of pulling a red tab or cap to presumably prepare the device for intramuscular or subcutaneous administration. The labeled dosages on the device indicate measurements for dosing.*

FDA Label Image

Figure (Htr Hnc 5 V2)

An instructional illustration showing a hand holding a pen-like injector device, with the device being pressed against the skin on the other hand's forearm. A red arrow points to the button being pressed, indicating the action of administering an injection, consistent with subcutaneous or intramuscular use.*

FDA Label Image

Figure (Htr Hnc 6 V2)

Close-up illustration of a dosage dial on a Humatrope kit syringe, showing the dose setting window with a reading of 0.00 units. The dial is white with a green trim, designed for precise dose measurement for intramuscular or subcutaneous administration.*

FDA Label Image

Package Label – Humatrope 6 mg Cartridge Kit (Humatrope 6mg Cart Kit Nl071)

Packaging label for Humatrope 6 mg Cartridge Kit, a somatropin injection for single-patient use. The carton states it is for use only with the separately supplied HumatroPen 6 mg injection device. The label includes storage instructions to refrigerate, not freeze, and not shake. The kit contains one 6 mg cartridge and one prefilled diluent syringe. Manufactured by Eli Lilly and Company, with a barcode and detailed ingredient and reconstitution information.*

FDA Label Image

Package Label – Humatrope 6 mg Cartridge Kit (Humatrope 6mg Cart Kit Nl072)

Packaging label for Humatrope 6 mg Cartridge Kit containing somatropin for injection, in a single-patient-use kit. It specifies use only with HumatroPen 6 mg device, supplied separately. The label includes storage instructions: refrigerate, do not freeze or shake, and lists kit contents—a cartridge and a prefilled diluent syringe. Manufacturer is Eli Lilly and Company.*

FDA Label Image

Package Label – Humatrope 12 mg Cartridge Kit (Humatrope 12mg Cart Kit Nl061)

Packaging label for HUMATROPE 12 mg Cartridge Kit (somatropin) by Eli Lilly and Company. The kit includes one 12 mg cartridge and one prefilled diluent syringe for injection. The label highlights single-patient-use instructions, storage conditions (refrigerate, do not freeze or shake), and that it is for use only with the HumatroPen 12 mg injection device. It includes regulatory and manufacturer information, barcode, and detailed contents of the cartridge and diluent syringe.*

FDA Label Image

Package Label – Humatrope 12 mg Cartridge Kit (Humatrope 12mg Cart Kit Nl062)

Humatrope 12 mg Cartridge Kit packaging label for somatropin injection. The label indicates it is a single-patient-use kit for intramuscular or subcutaneous administration, to be used only with the HumatroPen 12 mg injection device supplied separately. The kit contains one Humatrope cartridge and one prefilled diluent syringe. It includes storage instructions to refrigerate, do not freeze, and do not shake. Manufactured by Eli Lilly and Company.*

FDA Label Image

Package Label – Humatrope 24 mg Cartridge Kit (Humatrope 24mg Cart Kit Nl063)

Humatrope 24 mg Cartridge Kit packaging label for somatropin injection. The label indicates single-patient use with HumatroPen 24 mg injection device, supplied separately. The kit contains one Humatrope Cartridge 24 mg and one prefilled diluent syringe. Manufactured by Eli Lilly and Company for intramuscular or subcutaneous use. Includes storage instructions: refrigerate, do not freeze or shake. Contains detailed ingredient list for cartridge and syringe, and a barcode on the back panel.*

FDA Label Image

Package Label – Humatrope 24 mg Cartridge Kit (Humatrope 24mg Cart Kit Nl064)

HUMATROPE 24 mg Cartridge Kit packaging label for somatropin injection by Eli Lilly and Company. The label indicates it is for single-patient use only with the HumatroPen 24 mg injection device, supplied separately. Includes storage instructions to refrigerate without freezing or shaking, kit contents listing one cartridge and one prefilled diluent syringe, and ingredients details for the cartridge and diluent syringe. The label also notes it is for parenteral use only and that the container is not child resistant.*

FDA Label Image

Package Label – Humatrope 6 mg Pen (Htr Symbols V1)

FDA Label Image

Package Label – Humatrope 6 mg Pen (Humatrope 6mg Carton Pen Nl007)

Packaging label for Humatropen 6 mg, a growth hormone delivery system containing somatropin. The label depicts the injection device for use with Humatropen 6 mg cartridges, indicating it is recommended for use with Becton, Dickinson and Company pen needles. The label also features the Eli Lilly and Company logo and provides storage temperature information (-40°F to 158°F). The design includes images of the Humatropen device and details about included contents such as the pen case, drug cartridge, and user manuals.*

FDA Label Image

Package Label – Humatrope 12 mg Pen (Humatrope 12mg Carton Pen Nl008)

Packaging label for HumatroPen 12 mg, a growth hormone delivery system by Eli Lilly and Company. The label shows an image of the HumatroPen device and specifies it is an injection device for use with Humatrope (somatropin) 12 mg cartridges. The label also notes that pen needles are not included and provides product contents and handling instructions.*

FDA Label Image

Package Label – Humatrope 24 mg Pen (Humatrope 24mg Carton Pen Nl009)

Packaging label for HumatroPen 24 mg, a growth hormone delivery system by Eli Lilly and Company. The label shows the injection device designed for use with Humatrope (somatropin) 24 mg cartridges. It specifies that the product is an injection device and excludes cartridges and needles. The design includes dosage strength, brand logos, and regulatory symbols.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.